Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CANabidiol Use for RElief of Short Term Insomnia (CAN-REST). A Randomised, Double-Blind, Placebo-Controlled Clinical Study

NCT05253417 is registered in ClinicalTrials.gov with Bod Australia as lead sponsor.

NCT NCT05253417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05253417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CANabidiol Use for RElief of Short Term Insomnia (CAN-REST). A Randomised, Double-Blind, Placebo-Controlled Clinical Study
Lead sponsor
Bod Australia
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2022
Completion date
July 7, 2023
Enrollment
208 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, insomnia due to anxiety and fear, insomnia due to other mental disorder, insomnia type; sleep disorder, insomnia, transient, sleep disturbance